Vivavision Biotech

Developer of therapeutic solutions for treating multiple eye diseases

placePudong, Shanghai, China calendar_todayFounded 2016 language vivavisionbio.com

Innovation

11 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 71 times.

YearFilings
20191
20202
20212
20221
20231
20248
20256
20262

Investor mix

8 investors on record; lead investors include Viva BioInnovator, Sequoia Capital China.

Investor typeCountShare
Venture capital563%
Private equity225%
Other / undisclosed113%
Coming soon